Stock Scorecard

Stock Summary for Precigen Inc (PGEN) - $3.89 as of 9/16/2025 9:08:33 PM EST

Total Score

4 out of 30

Safety Score

30 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for PGEN

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for PGEN

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for PGEN

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for PGEN

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for PGEN (30 out of 100)

Stock Price Rating (Max of 10) 3
Historical Stock Price Rating (Max of 10) 3
Stock Price Trend (Max of 10) 7
Book Value (Max of 10) 1
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 2
Analyst Strong Buy Ratings (Max of 5) 4
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 10
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for PGEN

These 2 Healthcare Stocks More Than Doubled Recently and Could Soar Higher, According to Wall Street Analysts 9/7/2025 12:23:00 PM
Macy's Increases FY2025 Outlook, Joins REV Group, HealthEquity, Alphabet and Wellness And Other Big Stocks Moving Higher On Wednesday - Cogent Biosciences ( NASDAQ:COGT ) , Alkermes ( NASDAQ:ALKS ) 9/3/2025 2:10:00 PM
INO Stock Soars as FDA Backs Rolling BLA for Rare Lung Disease Drug 8/28/2025 2:00:00 PM
PGEN Stock Surges 144% in August on FDA Nod for Rare Lung Disease Drug 8/25/2025 3:04:00 PM
SelectQuote Posts Better-Than-Expected Results, Joins Nutex Health, NIO, MINISO Group And Other Big Stocks Moving Higher On Thursday - CEA Industries ( NASDAQ:BNC ) , MINISO Group Holding ( NYSE:MNSO ) 8/21/2025 3:32:00 PM
Intel, Plymouth Industrial REIT, Premier And Other Big Stocks Moving Higher On Tuesday - Heartland Express ( NASDAQ:HTLD ) , Intel ( NASDAQ:INTC ) 8/19/2025 3:00:00 PM
Why Palo Alto Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket - Color Star Tech ( NASDAQ:ADD ) , Adecoagro ( NYSE:AGRO ) 8/19/2025 12:01:00 PM
Fabrinet, Adecoagro And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Fabrinet ( NYSE:FN ) , Adecoagro ( NYSE:AGRO ) 8/19/2025 10:21:00 AM
Crude Oil Down 1%; US Retail Sales Rise 0.5% In July - Gambling.com Gr ( NASDAQ:GAMB ) , Nutex Health ( NASDAQ:NUTX ) 8/15/2025 4:28:00 PM
This Salesforce Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Friday - Kennametal ( NYSE:KMT ) , Salesforce ( NYSE:CRM ) 8/15/2025 2:39:00 PM

Financial Details for PGEN

Company Overview
Ticker PGEN
Company Name Precigen Inc
Country USA
Description Precigen, Inc. discovers and develops the next generation of cell and gene therapies in the United States. The company is headquartered in Germantown, Maryland.
Sector Name HEALTHCARE
Industry Name BIOTECHNOLOGY
Most Recent Quarter 6/30/2025
Next Earnings Date 11/12/2025

Stock Price History
Last Day Price 3.89
Price 4 Years Ago 3.71
Last Day Price Updated 9/16/2025 9:08:33 PM EST
Last Day Volume 9,288,962
Average Daily Volume 13,694,798
52-Week High 5.22
52-Week Low 0.65
Last Price to 52 Week Low 498.46%

Valuation Measures
Trailing PE N/A
Industry PE 21.46
Sector PE 40.64
5-Year Average PE -4.89
Free Cash Flow Ratio 77.80
Industry Free Cash Flow Ratio 13.30
Sector Free Cash Flow Ratio 29.51
Current Ratio Most Recent Quarter 2.71
Total Cash Per Share 0.05
Book Value Per Share Most Recent Quarter -0.12
Price to Book Ratio 7.25
Industry Price to Book Ratio 29.01
Sector Price to Book Ratio 32.14
Price to Sales Ratio Twelve Trailing Months 260.21
Industry Price to Sales Ratio Twelve Trailing Months 42.18
Sector Price to Sales Ratio Twelve Trailing Months 19.15
Analyst Buy Ratings 1
Analyst Strong Buy Ratings 2

Share Statistics
Total Shares Outstanding 297,973,000
Market Capitalization 1,159,114,970
Institutional Ownership 66.81%

Dividends
Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 1
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement
Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -31.63%
Reported EPS 12 Trailing Months -0.39
Reported EPS Past Year -0.27
Reported EPS Prior Year -0.32
Net Income Twelve Trailing Months -124,500,000
Net Income Past Year -126,235,000
Net Income Prior Year -95,904,000
Quarterly Revenue Growth YOY 19.40%
5-Year Revenue Growth -46.64%
Operating Margin Twelve Trailing Months -3,254.00%

Balance Sheet
Total Cash Most Recent Quarter 13,760,000
Total Cash Past Year 29,517,000
Total Cash Prior Year 7,578,000
Net Cash Position Most Recent Quarter -29,459,000
Net Cash Position Past Year -13,702,000
Long Term Debt Past Year 43,219,000
Long Term Debt Prior Year 43,219,000
Total Debt Most Recent Quarter 43,219,000
Equity to Debt Ratio Past Year 0.61
Equity to Debt Ratio Most Recent Quarter -5.71
Total Stockholder Equity Past Year 66,730,999
Total Stockholder Equity Prior Year 118,498,000
Total Stockholder Equity Most Recent Quarter -36,779,000

Free Cash Flow
Free Cash Flow Twelve Trailing Months -69,432,000
Free Cash Flow Per Share Twelve Trailing Months -0.23
Free Cash Flow Past Year -76,757,000
Free Cash Flow Prior Year -68,466,000

Options
Put/Call Ratio 0.37
Has Options Options Chain
Liquidity Rating

Technical Analysis
Yahoo Finance Chart Yahoo Finance Chart
MACD 0.56
MACD Signal 0.63
20-Day Bollinger Lower Band -0.07
20-Day Bollinger Middle Band 2.17
20-Day Bollinger Upper Band 4.40
Beta 1.82
RSI 62.68
50-Day SMA 1.55
150-Day SMA 1.43
200-Day SMA 1.65

System
Modified 9/16/2025 7:25:34 AM EST